Synergistic Prosthetic Heart Valve Systems with AI, IoT, Blockchain, and Advanced Materials

The present disclosure relates to novel, integrated prosthetic heart valve systems that combine advanced materials, artificial intelligence, Internet of Things (IoT) sensors, and blockchain technology to enhance valve performance, predict potential failures, and improve patient outcomes.

The original patent disclosed a prosthetic heart valve with a pericardial sealing member. However, the valve's performance and maintenance were limited by the lack of real-time monitoring, personalized optimization, and secure data sharing. The present inventive concept addresses these limitations by integrating AI, IoT, blockchain, and advanced materials to create a more powerful, connected, and patient-centric system.

The synergistic prosthetic heart valve system comprises a prosthetic heart valve with a pericardial sealing member, which can be made from advanced materials such as nanomaterials for improved biocompatibility and durability. The valve is integrated with an IoT sensor that transmits data to a remote monitoring system, enabling real-time tracking of valve performance. The system further includes a machine learning algorithm that analyzes the sensor data and provides personalized recommendations for valve maintenance and replacement. Additionally, the system utilizes a blockchain-based health record system to securely store and share valve-related data with healthcare providers. This integrated system enables early detection of potential valve failures, reduces healthcare costs, and improves patient outcomes.

The inventive concept's novelty lies in the synergistic combination of advanced materials, AI, IoT, and blockchain technologies to create a more powerful, connected, and patient-centric prosthetic heart valve system. The inventive step is the integration of these distinct technologies to achieve a system that is greater than the sum of its parts.

Alternative embodiments of the inventive concept include using different types of advanced materials, such as graphene or metamaterials, for the pericardial sealing member. Variations of the system could also include the integration of additional sensors, such as pressure or flow sensors, to provide more comprehensive valve performance data.

The synergistic prosthetic heart valve system has significant commercial potential in the medical device industry, particularly in the areas of cardiovascular health and personalized medicine. The system's ability to predict potential valve failures and enable early intervention could reduce healthcare costs and improve patient outcomes, making it an attractive solution for healthcare providers and patients alike.